Identification of Novel Adeno-Associated Virus Serotypes for Use as Vectors

Gene Therapy of the Central Nervous System: From Bench to Bedside

Volumn , Issue , 2006, Pages 17-24

  Vandenberghe, Luk H ^a   Wilson, James M ^b   Gao, Guangping ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247235808     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012397632-1/50003-4     Document Type: Chapter

References (68)

1. Arbetman A., Lochrie M., Randlev B., Surosky R., Zhou S., Wellman J., Pater C., Lehmkuhl H., Hobbs L., Pierce G., Colosi P. Isolation of a close AAV5 relative from goat tissues: evidence of host promiscuity. ASGT VIIth Annual Meeting 2004.
2. Arbetman A., Lochrie M., Surosky R., Randlev B., Zhou S., Wellman J., Lemkuhl H., Hobbs L.A., Peierce G., Colosi P. Characterization of novel caprine and bovine AAV capsids with unique transduction and neutralization properties. Xth Parvovirus Workshop 2004.
3. Atchison R.W., Casto B.C., Hammon W.M. Adenovirus-associated defective virus particles. Science 1965, 149:754-756.
4. Auricchio A., Kobinger G., Anand V., Hildinger M., O'Connor E., Maguire A.M., Wilson J.M., Bennett J. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum. Mol. Genet. 2001, 10(26):3075-3081.
5. Bantel-Schaal U., Delius H., Schmidt R., zur Hausen H. Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J. Virol. 1999, 73(2):939-947.
6. Bantel-Schaal U., Zur Hausen H. Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 1984, 134:52-63.
7. Bartlett J.S., Wilcher R., Samulski R.J. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 2000, 74(6):2777-2785.
8. Blacklow N.R., Hoggan M.D., Kapikian A.Z., Austin J.B., Rowe W.P. Epidemiology of adenovirus-associated virus infection in a nursery population. Am. J. Epidemiol. 1968, 88:368-378.
9. Blacklow N.R., Hoggan M.D., Rowe W.P. Isolation of adenovirus-associated viruses from man. Proc. Natl. Acad. Sci. 1967, 58:1410-1415.
10. Blacklow N.R., Hoggan M.D., Rowe W.P. Serologic evidence for human infection with adenovirus-associated viruses. J. Natl. Cancer Inst. 1968, 40(2):319-327.
11. Bossis I., Chiorini J.A. Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles. J. Virol. 2003, 77(12):6799-6810.
12. Brown K.E., Green S.W., Young N.S. Goose parvovirus-an autonomous member of the dependovirus genus?. Virology 1995, 210(2):283-291.
13. Carter B.J. Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective. Mol. Ther. 2004, 10(6):981-989.
14. Chao H., Monahan P.E., Liu Y., Samulski R.J., Walsh C.E. Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 sero-type vectors. Mol. Ther. 2001, 4(3):217-222.
15. Chen C., Jensen R., Schnepp B., Clark K.R., Johnson P. Characterization of adeno-associated virus sequences in human tissues. Mol. Ther. 2004, 9(Suppl 1):132.
16. Chenuaud P., Larcher T., Rabinowitz J.E., Provost N., Cherel Y., Casadevall N., Samulski R.J., Moullier P. Autoimmune anemia in macaques following erythropoietin gene therapy. Blood 2004, 103(9):3303-3304.
17. Chirmule N., Propert K., Magosin S., Qian Y., Qian R., Wilson J. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther 1999, 6(9):1574-1583.
18. Clark K.R., Chen C., Jensen R., Schnepp B., Johnson P. Characterization of wild-type adeno-associated viruses isolated from human tissues. Xth Parvovirus Workshop 2004.
19. Colosi E.A. Xth Parvovirus Workshop 2004.
20. Colosi E.A. Xth Parvovirus Workshop 2004.
21. Davidson B.L., Stein C.S., Heth J.A., Martins I., Kotin R.M., Derksen T.A., Zabner J., Ghodsi A., Chiorini J.A. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. USA 2000, 97(7):3428-3432.
22. Di Pasquale G., Rzadzinska A., Schneider M.E., Bossis I., Chiorini J.A., Kachar B. A novel bovine virus efficiently transduces inner ear neuroepithelial cells. Mol. Ther. 2005, 11(6):849-855.
23. Duan D., Yue Y., Yan Z., Yang J., Engelhardt J.F. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J. Clin. Invest. 2000, 105(11):1573-1587.
24. Farkas S.L., Zadori Z., Benko M., Essbauer S., Harrach B., Tijssen P. A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus. J. Gen. Virol. 2004, 85(Pt 3):555-561.
25. Ferrari F.K., Samulski T., Shenk T., Samulski R.J. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 1996, 70(5):3227-3234.
26. Fisher K.J., Gao G.P., Weitzman M.D., DeMatteo R., Burda J.F., Wilson J.M. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 1996, 70(1):520-532.
27. Gao G., Alvira M.R., Somanathan S., Lu Y., Vandenberghe L.H., Rux J.J., Calcedo R., Sanmiguel J., Abbas Z., Wilson J.M. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. USA 2003, 100(10):6081-6086.
28. Gao G.P., Alvira M.R., Wang L., Calcedo R., Johnston J., Wilson J.M. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 2002, 99(18):11854-11859.
29. Gao G., Lebherz C., Weiner D.J., Grant R., Calcedo R., McCullough B., Bagg A., Zhang Y., Wilson J.M. Erythropoietin gene therapy leads to autoimmune anemia in macaques. Blood 2004, 103(9):3300-3302.
30. Gao G., Vandenberghe L.H., Alvira M.R., Lu Y., Calcedo R., Zhou X., Wilson J.M. Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 2004, 78(12):6381-6388.
31. Georg-Fries B., Biederlack S., Wolf J., zur Hausen H. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 1984, 134(1):64-71.
32. Gregorevic P., Blankinship M.J., Allen J.M., Crawford R.W., Meuse L., Miller D.G., Russell D.W., Chamberlain J.S. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med. 2004, 10(8):828-834.
33. Grimm D., Kay M.A. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther. 2003, 3(4):281-304.
34. Grimm D., Zhou S., Nakai H., Thomas C.E., Storm T.A., Fuess S., Matsushita T., Allen J., Surosky R., Lochrie M., Meuse L., McClelland A., Colosi P., Kay M.A. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. Blood 2003, 102(7):2412-2419.
35. Hoggan M.D., Blacklow N.R., Rowe W.P. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc. Natl. Acad. Sci. USA 1966, 55(6):1467-1474.
36. Jensen R., Schnepp B., Johnson P., Clark K. Adeno-associated virus infection in non-human primates. Xth Parvovirus Workshop 2004.
37. Kaludov N., Brown K.E., Walters R.W., Zabner J., Chiorini J.A. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 2001, 75(15):6884-6893.
38. Kotin R.M. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 1994, 5(7):793-801.
39. Kotin R.M., Linden R.M., Berns K.I. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 1992, 11(13):5071-5078.
40. Lebherz C., Gao G., Louboutin J.P., Millar J., Rader D., Wilson J.M. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia. J. Gene Med. 2004, 6(6):663-672.
41. Lizardi P.M., Huang X., Zhu Z., Bray-Ward P., Thomas D.C., Ward D.C. Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat. Genet. 1998, 19(3):225-232.
42. Lukashov V.V., Goudsmit J. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses. J. Virol. 2001, 75(6):2729-2740.
43. Mayor H.D., Ito M. Distribution of antibodies to Type 4 adeno-associated satellite virus in simian and human sera. P. S. E. B. M. 1967, 26:723-725.
44. Mayor H.D., Melnick J.L. Small deoxyribonucleic acid-containing viruses (Picodnavirus group). Nature 1966, 210:331-332.
45. McCarty D.M., Young S.M., Samulski R.J. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 2004, 38:819-845.
46. Melnick J.L., Mayor H.D., Smith K.O., Rapp F. Association of 20 millimicron particles with adenoviruses. J. Bacteriol. 1965, 90:271-274.
47. Mori S., Wang L., Takeuchi T., Kanda T. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Virology 2004, 330(2):375-383.
48. Qing K., Hansen J., Weigel-Kelley K.A., Tan M., Zhou S., Srivastava A. Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J. Virol. 2001, 75(19):8968-8976.
49. Qing K., Mah C., Hansen J., Zhou S., Dwarki V., Srivastava A. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 1999, 5(1):71-77.
50. Rabinowitz J.E., Bowles D.E., Faust S.M., Ledford J.G., Cunningham S.E., Samulski R.J. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups. J. Virol. 2004, 78(9):4421-4432.
51. Rabinowitz J.E., Samulski J. Adeno-associated virus expression systems for gene transfer. Curr. Opin. Biotechnol. 1998, 9(5):470-475.
52. Rutledge E.A., Halbert C.L., Russell D.W. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 1998, 72(1):309-319.
53. Samulski R.J., Berns K.I., Tan M., Muzyczka N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA 1982, 79(6):2077-2081.
54. Samulski R.J., Chang L.S., Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 1989, 63(9):3822-3828.
55. Samulski R.J., Srivastava A., Berns K.I., Muzyczka N. Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell 1983, 33(1):135-143.
56. Sanlioglu S., Monick M.M., Luleci G., Hunninghake G.W., Engelhardt J.F. Rate limiting steps of AAV transduction and implications for human gene therapy. Curr. Gene Ther. 2001, 1(2):137-147.
57. Sarkar R., Tetreault R., Gao G., Wang L., Bell P., Chandler R., Wilson J.M., Kazazian H.H. Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype. Blood 2004, 103(4):1253-1260.
58. Schmidt M., Katano H., Bossis I., Chiorini J.A. Cloning and characterization of a bovine adeno-associated virus. J. Virol. 2004, 78(12):6509-6516.
59. Summerford C., Bartlett J.S., Samulski R.J. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 1999, 5(1):78-82.
60. Summerford C., Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 1998, 72(2):1438.
61. Thomas C.E., Storm T.A., Huang Z., Kay M.A. Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J. Virol. 2004, 78(6):3110-3122.
62. Walters R.W., Yi S.M., Keshavjee S., Brown K.E., Welsh M.J., Chiorini J.A., Zabner J. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 2001, 276(23):20610-20616.
63. Wang L., Calcedo R., Nichols T., Bellinger D., Dillow A., Verma I., Wilson J. Sustained correction of disease in naïve and AAV2-pretreated Hemophilia B dogs: AAV2/8 mediated, liver-directed gene therapy. Blood 2005, 105(8):3079-3086.
64. Xiao W., Chirmule N., Berta S.C., McCullough B., Gao G., Wilson J.M. Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 1999, 73(5):3994-4003.
65. Xiao X., Li J., Samulski R.J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 1998, 72(3):2224-2232.
66. Zabner J., Seiler M., Walters R., Kotin R.M., Fulgeras W., Davidson B.L., Chiorini J.A. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 2000, 74(8):3852-3858.
67. Zadori Z., Stefancsik R., Rauch T., T. Kisary T. Analysis of the complete nucleotide sequences of goose and muscovy duck parvoviruses indicates common ancestral origin with adeno-associated virus 2. Virology 1995, 212(2):562-573.
68. Zhu Profound cardiac and whole-body functional recovery in heart failure/muscular dystrophy hamsters by systemic delivery of AAV8 vectors via I.V. or I.P. route. Xth Parvovirus Workshop 2004.